KMTS Kestra Medical Technologies, Lt
$22.85▼ -3.05%
Healthcare
Other
After hours
$23.18▲ +1.44%
Sep 11, 7:48 PM ET
Volume 241.6K
Avg Volume (10D) 265.4K
Key Metrics & Fundamentals
Market Cap
$1.34B
P/E Ratio
–
Div Yield
–%
52W Range
17.34 - 30.00
% vs 50 MA
-9.92%
% vs 200 MA
-2.98%
RSI-14
32.8
MACD Histogram
-0.4600
Beta (1Y vs SPY)
1.63
Free Cash Flow
-$28.39M
Gross Rev
$28.64M
Gross Profit
$15.68M
EBITDA
-$34.47M
COGS
$12.96M
Operating Exp
$55.03M
Operating Income
-$39.34M
EBIT
-$39.34M
Pretax Income
-$38.64M
Net Income
-$38.84M
EPS (Diluted)
-0.67
Price & Volume History
Loading chart…
Recent News
AI Infrastructure Stock Forgent Power, Cardiovascular Play Kestra In Earnings Spotlight
Investor's Business Daily · Sep 11, 2026 6:56 PM
Kestra Medical Technologies Ltd (KMTS) Q1 2027 Earnings Report Preview: What To Look For
GuruFocus.com · Sep 11, 2026 1:15 PM
Kestra Names Daniel Finney Vice President of Research & Development
GlobeNewswire · Sep 10, 2026 10:00 AM
Analysts Estimate Kestra Medical Technologies, Ltd. (KMTS) to Report a Decline in Earnings: What to Look Out for
Zacks · Sep 7, 2026 2:00 PM
Phreesia (PHR) Q2 Earnings and Revenues Lag Estimates
Zacks · Sep 2, 2026 9:10 PM
Medtronic (MDT) Q1 Earnings and Revenues Top Estimates
Zacks · Sep 1, 2026 11:55 AM
Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14
GlobeNewswire · Aug 31, 2026 8:01 PM
Phibro Animal Health (PAHC) Tops Q4 Earnings and Revenue Estimates
Zacks · Aug 26, 2026 9:35 PM
Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience
GlobeNewswire · Aug 26, 2026 10:00 AM
Apple downgraded, HPE upgraded: Wall Street's top analyst calls
The Fly · Aug 10, 2026 1:39 PM
Financial Overview - Income Statement
Quarterly
Apr 2026
See KMTS's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.